Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

WhiteOak Capital Pharma and Healthcare Fund · Regular ✕HDFC MNC Fund · Regular ✕

Growth of ₹10,000

Basics

WhiteOak Capital Pharma and Healthcare FundHDFC MNC Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseWhiteOakHDFC
NAV₹17.5790₹14.1460
NAV date20 Nov 202620 Nov 2026
History2.8 years3.7 years
Expense ratio2.7%2.9%
StarsNot rated★★★★★
Growth Score—20.10

Returns

WhiteOak Capital Pharma and Healthcare FundHDFC MNC Fund
1 month+11.83%+7.48%
3 months+4.86%−1.01%
6 months+16.09%+7.48%
YTD+27.99%+4.41%
1 year+24.66%+5.45%
3 years (CAGR)—+6.63%
5 years (CAGR)——
10 years (CAGR)——
Since launch+22.13%+9.78%

Risk

WhiteOak Capital Pharma and Healthcare FundHDFC MNC Fund
Volatility—17.0%
Downside volatility—12.7%
Sharpe—0.01
Sortino—0.01
Calmar—0.27
Return / risk—0.39
Deepest fall−15.62%−24.89%
Days to recover137—
Below its high−0.05%−8.17%

Against benchmark

WhiteOak Capital Pharma and Healthcare FundHDFC MNC Fund
Alpha—−4.91%
Beta—0.87
R²—89.2%
Up capture—79.4%
Down capture—96.9%
Tracking error—6.1%
Information ratio—−0.95
Treynor—−0.00

Consistency

WhiteOak Capital Pharma and Healthcare FundHDFC MNC Fund
Best 1-year+33.22%+34.44%
Middle 1-year+16.64%+2.77%
Worst 1-year−1.11%−12.25%
1-year periods with a loss1.4%38.8%
Middle 3-year—+6.78%
Positive months—63.9%
Best day+3.87%+3.17%
Worst day−3.51%−3.83%
Worst 5% day−1.53%−1.51%
Positive days55.7%53.9%
NAVs a year247247

SIP of ₹10,000 a month

WhiteOak Capital Pharma and Healthcare FundHDFC MNC Fund
5-year XIRR——
5-year value——
3-year XIRR—+4.31%
1-year XIRR+34.56%+9.60%

Holdings overlap i

Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
  • WhiteOak Capital Pharma and Healthcare Fund: no monthly portfolio filing from WhiteOak is loaded yet, so it is left out here.
  • HDFC MNC Fund: no monthly portfolio filing from HDFC is loaded yet, so it is left out here.

Search Growth